Imeik Technology Development Co.,Ltd.
300896.SZ
Get informed when a big investor buys or sells
+ FollowMarket Cap$28.76B
Close$
$202.93
112.9% upside
Current Fair Value
112.9% upsideUndervalued by 112.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $28.76 Billion |
|---|---|
| Enterprise Value | $27.13 Billion |
| Dividend Yield | $2.00 (1.89%) |
| Earnings per Share | $4.28 |
| Beta | 0.61 |
| Outstanding Shares | 301,426,187 |
Return
| Return on Equity | 13.84% |
|---|---|
| Return on Assets | 11.87% |
| Return on Invested Capital | 14.40% |
Valuation & Multiples
| P/E Ratio | 26.11 |
|---|---|
| PEG | -178.37 |
| Price to Sales | 13.61 |
| Price to Book Ratio | 3.4 |
| Enterprise Value to Revenue | 11.45 |
| Enterprise Value to EBIT | 21.83 |
| Enterprise Value to Net Income | 24 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.04 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 20, 2026
EPS Estimate
$1.27
Average shareholder expectationRevenue Estimate
$724.25 M
Average shareholder expectationNext Earnings Call
Expected Date
October 29, 2026
EPS Estimate
$0.98
Average shareholder expectationRevenue Estimate
$579.93 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Imeik Technology Development Co.,Ltd.
1,458 employees
CEO: Yifeng Shi Imeik Technology Development Co.,Ltd. specializes in the research, development, manufacturing, and distribution of biomedical materials. The company's diverse product portfolio caters to both the medical aesthetics field and general skin...